Musiał-Kopiejka, M.;                     Polanowska, K.;                     Dobrowolski, D.;                     Krysik, K.;                     Wylęgała, E.;                     Grabarek, B.O.;                     Lyssek-Boroń, A.    
        The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. Int. J. Environ. Res. Public Health 2022, 19, 2303.
    https://doi.org/10.3390/ijerph19042303
    AMA Style
    
                                Musiał-Kopiejka M,                                 Polanowska K,                                 Dobrowolski D,                                 Krysik K,                                 Wylęgała E,                                 Grabarek BO,                                 Lyssek-Boroń A.        
                The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. International Journal of Environmental Research and Public Health. 2022; 19(4):2303.
        https://doi.org/10.3390/ijerph19042303
    
    Chicago/Turabian Style
    
                                Musiał-Kopiejka, Magdalena,                                 Katarzyna Polanowska,                                 Dariusz Dobrowolski,                                 Katarzyna Krysik,                                 Edward Wylęgała,                                 Beniamin Oskar Grabarek,                                 and Anita Lyssek-Boroń.        
                2022. "The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration" International Journal of Environmental Research and Public Health 19, no. 4: 2303.
        https://doi.org/10.3390/ijerph19042303
    
    APA Style
    
                                Musiał-Kopiejka, M.,                                 Polanowska, K.,                                 Dobrowolski, D.,                                 Krysik, K.,                                 Wylęgała, E.,                                 Grabarek, B. O.,                                 & Lyssek-Boroń, A.        
        
        (2022). The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. International Journal of Environmental Research and Public Health, 19(4), 2303.
        https://doi.org/10.3390/ijerph19042303